Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Meclofenamic acid sodium (Standard)
Cat. No.:
OB0425LY-363
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Meclofenamic acid sodium is a non-selective gap-junction blocker and a highly selective inhibitor of fat - and obesity-related.
Synonyms:
6385-02-0; Meclomen; Sodium meclofenamate; Meclofenamic acid sodium salt; Meclofenamic acid sodium; Meclonax; Movens; Sodium 2-((2,6-dichloro-3-methylphenyl)amino)benzoate; Benzoic acid, 2-((2,6-dichloro-3-methylphenyl)amino)-, monosodium salt, monohydrate
CAS No.:
6385-02-0
Compound CID:
4038
Formula:
C14H10Cl2NNaO2
Formula Weight:
318.13
Specification
Target:
Others
Pathway:
Others
Storage:
Storage at -20°C.
Applications:
Meclofenamic acid sodium is often used to relieve pain and inflammation.
